Clinical trial

Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.

NCT00202956 · Taichung Veterans General Hospital, Other · Unknown status

Key facts

NCT number NCT00202956
Title Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.
Official title A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effects on Biomarkers and Safety of Bugusan (BGS) in Postmenopausal Patients With Osteoporosis.
Lead sponsor Taichung Veterans General Hospital, Other
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions Osteoporosis
Intervention type Drug
Interventions Bugusan
Start date Jun 1, 2004
Completion May 1, 2005
First posted Sep 20, 2005
Last update posted Sep 20, 2005
Countries Taiwan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies